NCT04247126 2023-10-27A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid TumorsSyros PharmaceuticalsPhase 1 Completed105 enrolled
NCT02658214 2020-08-20Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsAstraZenecaPhase 1 Completed32 enrolled